These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17979654)

  • 21. Cytochrome P4503A (CYP3A) metabolism: prediction of in vivo activity in humans.
    Wilkinson GR
    J Pharmacokinet Biopharm; 1996 Oct; 24(5):475-90. PubMed ID: 9131486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons.
    Brandon EF; Raap CD; Meijerman I; Beijnen JH; Schellens JH
    Toxicol Appl Pharmacol; 2003 Jun; 189(3):233-46. PubMed ID: 12791308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Drug metabolism in the small intestine--the significance for biological availability].
    Andersen VC; Sonne J
    Ugeskr Laeger; 2000 May; 162(22):3215-9. PubMed ID: 10850220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestinal first-pass metabolism: bridging the gap between in vitro and in vivo.
    Galetin A
    Curr Drug Metab; 2007 Oct; 8(7):643-4. PubMed ID: 17979662
    [No Abstract]   [Full Text] [Related]  

  • 25. Potential role of intestinal first-pass metabolism in the prediction of drug-drug interactions.
    Galetin A; Gertz M; Houston JB
    Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):909-22. PubMed ID: 18624679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastrointestinal absorption of drugs: methods and studies.
    Barthe L; Woodley J; Houin G
    Fundam Clin Pharmacol; 1999; 13(2):154-68. PubMed ID: 10226759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Species and organ differences in first-pass metabolism of the ester prodrug L-751,164 in dogs and monkeys. In vivo and in vitro studies.
    Prueksaritanont T; Gorham LM; Ellis JD; Fernandez-Metzler C; Deluna P; Gehret JR; Strong KL; Hochman JH; Askew BC; Duggan ME; Gilbert JD; Lin JH; Vyas KP
    Drug Metab Dispos; 1996 Nov; 24(11):1263-71. PubMed ID: 8937862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of the intestinal permeability and first-pass metabolism of drugs in cynomolgus monkeys using single-pass intestinal perfusion.
    Takahashi M; Washio T; Suzuki N; Igeta K; Yamashita S
    Biol Pharm Bull; 2010; 33(1):111-6. PubMed ID: 20045946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut Wall Metabolism. Application of Pre-Clinical Models for the Prediction of Human Drug Absorption and First-Pass Elimination.
    Jones CR; Hatley OJ; Ungell AL; Hilgendorf C; Peters SA; Rostami-Hodjegan A
    AAPS J; 2016 May; 18(3):589-604. PubMed ID: 26964996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional Comparison of Human Colonic Carcinoma Cell Lines and Primary Small Intestinal Epithelial Cells for Investigations of Intestinal Drug Permeability and First-Pass Metabolism.
    Yamaura Y; Chapron BD; Wang Z; Himmelfarb J; Thummel KE
    Drug Metab Dispos; 2016 Mar; 44(3):329-35. PubMed ID: 26700954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental models for predicting drug absorption and metabolism.
    Alqahtani S; Mohamed LA; Kaddoumi A
    Expert Opin Drug Metab Toxicol; 2013 Oct; 9(10):1241-54. PubMed ID: 23687990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting drug-drug interactions involving the inhibition of intestinal CYP3A4 and P-glycoprotein.
    Tachibana T; Kato M; Takano J; Sugiyama Y
    Curr Drug Metab; 2010 Nov; 11(9):762-77. PubMed ID: 21189139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interplay of transporters and enzymes in drug and metabolite processing.
    Pang KS; Maeng HJ; Fan J
    Mol Pharm; 2009; 6(6):1734-55. PubMed ID: 19891494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gutsy science: In vitro systems of the human intestine to model oral drug disposition.
    Arian CM; Imaoka T; Yang J; Kelly EJ; Thummel KE
    Pharmacol Ther; 2022 Feb; 230():107962. PubMed ID: 34478775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-metabolizing activity of human and rat liver, lung, kidney and intestine slices.
    De Kanter R; De Jager MH; Draaisma AL; Jurva JU; Olinga P; Meijer DK; Groothuis GM
    Xenobiotica; 2002 May; 32(5):349-62. PubMed ID: 12065058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
    Singh SS
    Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of In Vitro Models for Assessment of Human Intestinal Metabolism in Drug Discovery.
    Davies M; Peramuhendige P; King L; Golding M; Kotian A; Penney M; Shah S; Manevski N
    Drug Metab Dispos; 2020 Nov; 48(11):1169-1182. PubMed ID: 32862146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of human pharmacokinetics--gut-wall metabolism.
    Fagerholm U
    J Pharm Pharmacol; 2007 Oct; 59(10):1335-43. PubMed ID: 17910807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in situ evaluation of herb-drug interactions during intestinal metabolism and absorption of baicalein.
    Fong YK; Li CR; Wo SK; Wang S; Zhou L; Zhang L; Lin G; Zuo Z
    J Ethnopharmacol; 2012 Jun; 141(2):742-53. PubMed ID: 21906668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intestinal absorption and metabolism of xenobiotics.
    Chhabra RS
    Environ Health Perspect; 1979 Dec; 33():61-9. PubMed ID: 540626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.